TROPIC BIOSCIENCES UK LIMITED

• ◆

  Material uncertainty over going concern

  The financing arrangements described above are currently non-binding so there is not sufficient committed cash flow to fund the business plan for a period of twelve months from the date of approval of the financial statements and additional funds will be required to continue as a going concern beyond that point. These conditions indicate the existence of a material uncertainty which may cast significant doubt about the Group's and Company's ability to continue as a going concern.

• ◆

  4 officer resignations in last 12 months

  Multiple officers have left the board recently — see the People section for who.

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers

Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Margin ratios are hidden where reported turnover is too small relative to profit to yield a meaningful figure — typical of holding companies whose income is mostly subsidiary dividends rather than trading revenue. Sector-distribution context coming next.

Accounting basis

FRS 102

Reporting scope

Consolidated group

Auditor

PricewaterhouseCoopers LLP

Audit opinion

Unqualified (clean)

Going concern

Material uncertainty disclosed

“The financing arrangements described above are currently non-binding so there is not sufficient committed cash flow to fund the business plan for a period of twelve months from the date of approval of the financial statements and additional funds will be required to continue as a going concern beyond that point. These conditions indicate the existence of a material uncertainty which may cast significant doubt about the Group's and Company's ability to continue as a going concern.”

Group structure

1. TROPIC BIOSCIENCES UK LIMITED · parent
   1. Tropic Biosciences (SG) PTE. LTD. 100% · Singapore · Research and experimental development on biotechnology

Significant events

• “In 2024, the Company set up a wholly owned subsidiary in Singapore ("Tropic Biosciences (SG) PTE. LTD.") and formed the Group.”
• “The Group anticipates the Reduced Browning and Extended Shelf Life varieties from its banana product pipeline will be available for sale in 2025 and has invested in its people and the resources needed to support this commercial activity. As part of this, the Group has made significant progress obtaining regulatory dearance for the commercialisation of these varieties. New commercial clearances have been achieved in Honduras, Colombia, USA and Canada, and for Reduced Browning only, the Philippines.”
• “On 29 January 2024, Tropic Biosciences (SG) PTE. LTD. was established as a wholly-owned subsidiary of the Company. As a result, these financial statements for the year ended 31 December 2024 are the first year that consolidated financial statements are prepared. In 2024, Tropic Biosciences (SG) PTE. LTD. is exempt from an audit. During the year, the Company has also established a branch in the Philippines.”
• “On the 9 May 2025 the convertible loan notes of one of the convertible loan note holders matured. Currently this has not been reflected in the conversion from debt to equity of 562,345 shares.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

20

last 12 months

Capital events

6

last 24 months

Officers appointed

3

last 12 months

Officers resigned

4

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.